Quantcast
FDA Approves Contrave A New Drug To Battle Obesity

FDA Approves Contrave, A New Drug To Battle Obesity

John Hopton for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has approved the weight loss pill Contrave, a medication that will be used to treat obese adults in conjunction with a controlled diet and exercise. It...

Latest FDA Stories

2014-09-16 23:16:48

On September 12, Hospira, Inc. announced the recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL due to particulate matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information...

2014-09-16 23:11:20

Expert dermatologist Dr. Mitchel Goldman of Cosmetic Laser Dermatology discusses the importance of only using FDA approved dermal fillers. San Diego, CA (PRWEB) September 16, 2014 A recent article discusses the dangers of an injectable substance used as a dermal filler, “Expression”, which has not been approved for cosmetic use. “Expression” was originally put on the market to be used as an intra-nasal splint following rhinoplasty, and was never approved by the FDA for use as a...

2014-09-16 12:31:25

SAN FRANCISCO, Sept. 16, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK((TM)) (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief...

2014-09-16 12:31:14

KENNEWICK, Wash., Sept. 16, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that a patent was awarded for technology related to its brachytherapy products. AMIC's rights for the newly issued patent arise from its license from Battelle, under which AMIC exclusively licensed...

2014-09-16 08:30:17

Innovative needle design to enhance patient safety LAWRENCE, Mass., Sept. 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite(TM), has received FDA clearance. http://photos.prnewswire.com/prnvar/20110503/MM94799LOGO The OneSite employs a unique dual lumen needle design offered in both a sharp version with MasterGuard® and a buttonhole version with SteriPick®...

2014-09-15 23:10:01

On September 9, the FDA announced that it requested the recall of sterile drug products by Downing Labs (aka NuVision Pharmacy) due to lack of sterility. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on sterile drug products. Following a...

2014-09-15 23:03:17

ComplianceOnline, the leading GRC advisory network, and regulatory affairs expert, Dr. Mukesh Kumar will conduct a two day seminar on requirements of SOPs for FDA-regulated industries. Durham, North Carolina (PRWEB) September 15, 2014 ComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations. The two day...

2014-09-15 08:29:16

PHILADELPHIA, September 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has accepted for filing with priority review a supplemental New Drug Application (sNDA) for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) as a treatment for adults with binge eating disorder (BED). The FDA is expected to provide a decision in February 2015, based on the...

2014-09-15 08:28:36

MONMOUTH JUNCTION, N.J., Sept. 15, 2014 /PRNewswire/ -- Vernalis plc (LSE: VER) and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S. Food and Drug Administration ("FDA") has confirmed that the New Drug Application ("NDA") for Tuzistra(TM) XR ("CCP-01") has been accepted for full review. This triggers a milestone payment from Vernalis to Tris. The FDA has set a Prescription Drug User Fee Act (PDUFA) target date for conclusion of its review of 30 April 2015. Under...

2014-09-12 23:06:24

On August 25, Tjs Place announced the recall of approx. 20 containers of Basil Pesto Pasta packed in 8 oz plastic tubs due to potential health risk. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 12, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Basil Pesto Pasta. Tjs Place announced on...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related